Our firm

Named people, standing behind named outcomes.

BCA is a regulated-market-access firm anchored on life sciences, with Germany as the EU gateway. We are deliberately small and senior — the people who read your market and carry your local relationships are the people you'll actually work with.

Why this page matters

Accountability is the product

The defensible part of this work isn't a strategy document — it's execution and named human accountability. So the firm has to be nameable.

Our thesis is that authorization isn't the same as getting paid, and that the hard, defensible layer is the relationships and execution that decide revenue. A firm making that claim with no named people behind it would contradict itself. So here we are, in the open: who we are, how we work, and the international reach we bring.

Our standard

Small, senior and accountable. The person who reads your market is the person in the room when it's negotiated. No anonymous hand-offs.

The team

The people you'll work with

Replace the placeholders below with real leads, credentials and a one-line track record each — this is the single most important block on the page.

RM

Ralf Müller

Market Access & Regulatory Lead

15 years in German pharma. A former product manager who has worked across the full regulatory landscape — G-BA, IQWiG, BfArM and the relevant authorities — and repeatedly built and led cross-functional project groups from dossier to launch.

Languages: German · English · French

AB

Alexander Baranov

Commercial & Partnerships Lead

7 years in pharma consulting and market entry, with launches and partner networks built across Austria, France, Canada, Korea and Germany. Leads discovery, partner and distributor search, and the commercial relationships that carry a launch on the ground.

Languages: English · German · Spanish

Published work

The same expertise, in long form

Alexander Baranov has turned the firm's market-entry and market-access thinking into published field guides — the long-form version of the work we do on the ground. Read the argument before we ever talk.

Pharma Gateway Series · Book One

The American Gateway

The outbound playbook for European pharmaceutical companies crossing the Atlantic — how to enter, price and win in the world's largest and most rule-bound drug market.

On Amazon
Germany · Tax

Taxing Germany

Not a filing manual — the missing explanation of why the German tax system works the way it does, for anyone who met it before they understood it.

On Amazon
EU · E-commerce

Selling into Europe

A practical playbook for structuring, warehousing and scaling an e-commerce business across the EU — and a candid look at the mistakes that quietly cost the most.

On Amazon
Germany · Go-to-market

Winning the German Customer

Germany is Europe's biggest online market and one of its most sceptical. How to earn its trust — the digital-marketing, credibility and market-entry playbook.

On Amazon
How we work

We own a layer, and orchestrate the rest

Being honest about the boundary is part of being credible. We own the commercial and relationship layer; we coordinate the specialists around it.

We own
  • Market & pricing-environment read
  • Positioning & comparator narrative
  • Partner, payer & hospital identification and approach
  • Local representation on the ground
  • Orchestration of the specialists into one plan
We coordinate
  • Regulatory submissions and benefit dossiers
  • Notified Body process and legal contracts
  • Pharmacovigilance and data-security certification
  • Clinical / health-economic studies
International reach

Germany as the anchor, the EU from there

BCA Group · Italy

Our international presence gives entrants a credible EU footprint beyond Germany — and gives German companies a partner network for going out. Germany first; the EU from there, in both directions.

We work with international companies entering Germany and the EU — drawing on hands-on market experience across Korea, Canada, France, Austria and Germany — and with German organizations taking products and equipment to markets abroad.

The through-line is the same either way: regulated, technically complex sectors where the entry barrier is real and a local guide is not optional.

Add when ready

Specialist partners you coordinate (regulatory, pharmacovigilance, Notified Body, data-security), any association memberships, and 2–3 anonymized cases (origin country, product class, outcome, rough timeline). These convert interest into trust.

Work with us

Talk to the people who'll actually do the work.

Start with a focused, low-risk session — you'll meet the lead who would run your engagement.

Book a session